Skip to main content

Day: March 7, 2022

Pharmaceutical Packaging Market to Hit $153.93 Billion by 2027 | Pharmaceutical Packaging Industry CAGR of 6.4%

Companies covered in the pharmaceutical packaging market are Amcor Plc, Gerresheimer AG, Origin Pharma Packaging, Nelipak Healthcare, Pharma Packaging Solutions, SCHOTT AG, Becton Dickinson & Company, West Pharmaceutical Services, Inc. WestRock, AptarGroup, Inc. Berry Global, Inc NIPRO, and more players profiled Pune, India, March 07, 2022 (GLOBE NEWSWIRE) — The global pharmaceutical packaging market size is expected to reach $153.93 billion by 2027, exhibiting a CAGR of 6.4% during the forecast period.  The growing adoption of novel and generic drugs in developing countries will have an excellent impact on the global market, The market size stood at $90.23 billion in 2019. The report on the pharmaceutical packaging market encompasses:Grander analysis of the market Important insights into the competitive landscape Factors...

Continue reading

International Money Express, Inc. Reports Record Transactions and Revenues for 2021 Fourth Quarter and Full Year

Digital and Emerging Markets Helped Fuel Record Growth Company to Host Conference Call Today at 9 a.m. ET Fourth Quarter 2021 – Highlights compared with the prior-year periodRecord Revenues of $127.2 million, an increase of 28.1% Net Income of $13.1 million, an increase of 36.5% Diluted EPS of $0.33, an increase of 32.0% Adjusted Net Income of $15.9 million, an increase of 35.7% Adjusted Diluted EPS of $0.40, an increase of 33.3% Adjusted EBITDA of $23.8 million, an increase of 27.1% A 20.5% increase in the number of active customers; and a 76.3% increase in digital customersFull Year 2021 – Highlights compared with the prior-year periodRecord Revenues of $459.2 million, an increase of 28.6% Record Net Income of $46.8 million, an increase of 38.7% Diluted EPS of $1.20, an increase of 36.4% Adjusted Net Income of $57.5 million,...

Continue reading

Aemetis to Review Fourth Quarter and Year-End 2021 Financial Results on March 10, 2022

CUPERTINO, CA , March 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year-end 2021 earnings report: Date: Thursday, March 10, 2022 Time: 11 am Pacific Standard Time (PST) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 395788 Live Participant Dial In (International): +1-973-528-0011 entry code 395788 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/44782 Attendees may submit questions during the Q&A portion of the conference call.  The webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls, along with the company presentation, recent announcements and video recordings. The voice recording will be available through March 17,...

Continue reading

Life Clips, Inc. Subsidiary Belfrics To Issue University Certificates On Its Blockchain For The Indian State Of Maharashtra

Universities in Maharashtra State India can now verify certificates within 10 seconds Belfrics to onboard more than 45 universities for issuing certificate Currently the academic degree verification and certification process used by universities is a manual process requiring human interventionAVENTURA, Fla., March 07, 2022 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) today announced its Belfrics subsidiary will issue all university level certificates to students in the State of Maharashtra, India on the Belrium blockchain. Mumbai, India’s financial and commercial center, is the capital of Maharashtra state. This will make Maharashtra India’s first state to use blockchain for educational certificates, as well as one of the world’s largest users of blockchain based educational certificates. Belfrics partner...

Continue reading

Alico, Inc. to Attend the 34th Annual Roth Conference

FORT MYERS, Fla., March 07, 2022 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that Richard Rallo, the Company’s Senior Vice President and Chief Financial Officer, will attend the 34th Annual Roth Conference to be held March 13-15, 2022 at the Ritz Carlton Laguna Niguel, located in Dana Point, California. The Company will be hosting one-on-one and small group meetings during the conference. For more information on the conference or to schedule a one-on-one meeting with Alico, Inc. please contact investor.relations@alicoinc.com. About Alico Alico, Inc. primarily operates two divisions: Alico Citrus, one of the nation’s largest citrus producers, and Land Management and Other Operations, which includes land leasing and related support operations. Learn more about Alico (Nasdaq: “ALCO”)...

Continue reading

Celebrating International Women’s Day, Duck Creek Technologies Highlights Female-led and Female-focused Sessions During Formation ’22, March 6-8, 2022

Inspiring guest speaker, Reshma Saujani, founder of Girls Who Code and Marshall Plan for Moms, and through Women’s Innovation Networking Event sponsored by Accenture, Duck Creek honors women in technology and insurance Boston, March 07, 2022 (GLOBE NEWSWIRE) — Duck Creek Technologies (NASDAQ: DCT), a leading, global technology solutions provider to the property and casualty (P&C) insurance industry, celebrates International Women’s Day during its annual user conference, Formation ’22, in Orlando, Florida, March 6-8, 2022. The event, which coincides with International Women’s Day on Tuesday, March 8, 2022, has a number of female-led and female-focused sessions that give women and allies an opportunity to engage in conversation around what is going on within the workplace and world. Duck Creek’s Chief People Officer, Courtney...

Continue reading

Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)

MINNEAPOLIS, March 07, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that an abstract for SBP-101, a proprietary polyamine analogue, has been accepted for poster presentation at the American Association for Cancer Research (AACR), which will be held April 8-13, 2022. The work reflects the Company’s on-going collaboration with Johns Hopkins University School of Medicine. Details of the presentation are as follows: Poster PresentationTitle: The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancerSession Category: Experimental and Molecular TherapeuticsSession Title: Small Molecule Therapeutic Agents Abstract...

Continue reading

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leads Out in Psychedelic-Based Therapeutics Space

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) — NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) announces the availability of a broadcast titled, “Psychedelic Therapies Offer Hope for Mental Health.” To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast To view the full editorial, please visit: https://nnw.fm/JeGwq There’s strong belief that different classes of psychedelics, such as ketamine, psilocybin, DMT and MDMA, can be developed for a wide range of unmet medical needs. These needs may include hard-to-treat disease and disorders such as anxiety, depression, addiction and post-traumatic stress, among others. In aggregate, mental health maladies affect more than 900 million people globally with direct and indirect economic costs of a staggering $2.5 trillion. Today, therapeutics protocols...

Continue reading

RAMSAY SANTE : Half-year Financial Report as at end of December 2021 disposal

   Paris, February 24, 2022        RAMSAY SANTE   Half-year Financial Report as at end of December 2021 disposal   This document is available on RAMSAY SANTE Internet site : http://www.ramsaygds.com About Ramsay Santé : After the successfull acquisition of Capio AB Group in 2018, Ramsay Santé is becoming one of the leaders of the hospitalisation and primary care in Europe with 36 000 employees and 8 600 practitioners serving 7 million patients in our 350 facilities in 5 countries : France, Sweden, Norway, Denmark and Italy. Ramsay Santé offers almost all medical and surgical specialities in three business areas : general hospitals (medicine – surgery – obstetric), follow-up care and rehabilitation clinics, mental health. In all its territories, the group contributes to missions of public service and to the territorial sanitory...

Continue reading

Day One Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Progress

Initial data from pivotal FIREFLY-1 study with DAY101 (tovorafenib) expected in June 2022 Targeted enrollment achieved in pivotal FIREFLY-1 study Topline results from pivotal FIREFLY-1 study expected in Q1 2023 Current cash provides runway into 2024 and through multiple expected key clinical milestones SOUTH SAN FRANCISCO, Calif., March 07, 2022 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced its fourth quarter and full year 2021 financial results and highlighted recent corporate achievements. “Our clinical and corporate achievements in 2021 have set a solid foundation for a potentially transformational next 12 months,” said Jeremy Bender,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.